Health Trials

EBV-associated Hemophagocytic Lymphohistiocytosis

1

Review clinical trials related to EBV-associated Hemophagocytic Lymphohistiocytosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection

This is a multi-center, single arm, open-label, phase I study to determine the safety and effectiveness of EBV-TCR-T cell immunotherapy in treating EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH) or EBV infection

Participants needed: 9
Trial details
Phase: Phase 1Age: 1-60Biological sex: AllType: InterventionalSponsor: Chinese PLA General HospitalUpdated: Nov 18, 2023Locations: 1
Eligibility criteria

Age 1-60 years, gender unlimited. [+4]

Patients with uncontrolled active aGVHD one day before TCR-T cell infusion. [+11]

Read more